Roger W. Blain

<i>In vitro</i> and <i>in vivo</i> activity of R547: a potent and selective cyclin-dependent kinase inhibitor currently in phase I clinical trials

Wanda DePinto, Xin‐Jie Chu, Xuefeng Yin et al. · Molecular Cancer Therapeutics · 2006 · 102 citations · Full text

Molecular Pharmacology, Tumor Biology, Cell Cycle Block +15

Pharmacokinetics, Safety, and Tolerability of R411, a Dual α4β1‐α4β7 Integrin Antagonist After Oral Administration at Single and Multiple Once‐Daily Ascending Doses in Healthy Volunteers

Youssef Hijazi, Horst A. Welker, Albert Dorr et al. · The Journal of Clinical Pharmacology · 2004 · 28 citations

Asthma, Molecular Pharmacology, Pharmacokinetic Modeling +12

Determination of hydrophobicity parameters on polybutadiene-coated alumina and their application in quantitative structure-activity relationships analysis

Roman Kaliszan, Jacek Petrusewicz, Roger W. Blain et al. · Journal of Chromatography A · 1988 · 27 citations

Materials Science, Engineering, Hydrophobicity Parameters +7

A new HPLC method of hydrophobicity evaluation employing poly (butadiene)-coated alumina columns

Roman Kaliszan, Roger W. Blain, Richard A. Hartwick · Chromatographia · 1988 · 23 citations

Materials Science, Chemical Engineering, Engineering +10